A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

NCT05156983 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

328

Enrollment

INDUSTRY

Sponsor class

Conditions

Coagulation Disorder

Interventions

DRUG: TAK-330
DRUG: SOC 4F-PCC

Sponsor

Takeda

Collaborators

[object Object]